mTORC1 activity suppresses ferroptosis through a SCARB1-dependent HDL-tocopherol uptake pathway
Open Access
- 16 April 2026
- journal article
- Published by Elsevier in Molecular Cell
- Vol. 86 (8) , 1546-1559.e8
Abstract
No abstract availableKeywords
Funding Information
- Elsa U. Pardee Foundation
- Pew Charitable Trusts
- National Cancer Institute
This publication has 77 references indexed in Scilit:
- A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancerInvestigational New Drugs, 2018
- A Kinase Inhibitor Targeted to mTORC1 Drives Regression in GlioblastomaCancer Cell, 2017
- Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cellsHepatology, 2015
- A Protein-Tagging System for Signal Amplification in Gene Expression and Fluorescence ImagingCell, 2014
- Genome-Scale CRISPR-Mediated Control of Gene Repression and ActivationCell, 2014
- CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in EukaryotesCell, 2013
- Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer CellsCancer Cell, 2012
- mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP PathwayCell, 2011
- AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and ActivityCancer Cell, 2011
- A Fluorometric Method for Measurement of Peroxyl Radical Scavenging Activities of Lipophilic AntioxidantsAnalytical Biochemistry, 1998